Yu X - Search Results

1

A common variant associated with prostate cancer in European and African populations.

Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Bälter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. Amundadottir LT, et al. Among authors: yu x. Nat Genet. 2006 Jun;38(6):652-8. doi: 10.1038/ng1808. Epub 2006 May 7. Nat Genet. 2006. PMID: 16682969

2

Prostate specific antigen density correlates with features of prostate cancer aggressiveness.

Kundu SD, Roehl KA, Yu X, Antenor JA, Suarez BK, Catalona WJ. Kundu SD, et al. Among authors: yu x. J Urol. 2007 Feb;177(2):505-9. doi: 10.1016/j.juro.2006.09.039. J Urol. 2007. PMID: 17222621

3

The association between total prostate specific antigen concentration and prostate specific antigen velocity.

Yu X, Loeb S, Roehl KA, Han M, Catalona WJ. Yu X, et al. J Urol. 2007 Apr;177(4):1298-302; discussion 1301-2. doi: 10.1016/j.juro.2006.12.003. J Urol. 2007. PMID: 17382716

4

Under diagnosis and over diagnosis of prostate cancer.

Graif T, Loeb S, Roehl KA, Gashti SN, Griffin C, Yu X, Catalona WJ. Graif T, et al. Among authors: yu x. J Urol. 2007 Jul;178(1):88-92. doi: 10.1016/j.juro.2007.03.017. Epub 2007 May 11. J Urol. 2007. PMID: 17499308

5

Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.

Loeb S, Roehl KA, Yu X, Han M, Catalona WJ. Loeb S, et al. Among authors: yu x. Urology. 2007 Jan;69(1):108-12. doi: 10.1016/j.urology.2006.09.040. Urology. 2007. PMID: 17270629

6

Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program.

Eggener SE, Yossepowitch O, Roehl KA, Loeb S, Yu X, Catalona WJ. Eggener SE, et al. Among authors: yu x. Urology. 2008 Jun;71(6):1016-9. doi: 10.1016/j.urology.2007.12.008. Epub 2008 Mar 21. Urology. 2008. PMID: 18358515

7

Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.

Loeb S, Roehl KA, Nadler RB, Yu X, Catalona WJ. Loeb S, et al. Among authors: yu x. J Urol. 2007 Dec;178(6):2348-52; discussion 2352-3. doi: 10.1016/j.juro.2007.08.016. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936844

8

Preoperative prostate specific antigen doubling time is not a useful predictor of biochemical progression after radical prostatectomy.

Loeb S, Kan D, Yu X, Roehl KA, Catalona WJ. Loeb S, et al. Among authors: yu x. J Urol. 2010 May;183(5):1816-21. doi: 10.1016/j.juro.2010.01.011. Epub 2010 Mar 29. J Urol. 2010. PMID: 20303104 Free PMC article.

9

Comparison of methods for calculating prostate specific antigen velocity.

Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, Catalona WJ. Yu X, et al. J Urol. 2006 Dec;176(6 Pt 1):2427-31; discussion 2431. doi: 10.1016/j.juro.2006.08.006. J Urol. 2006. PMID: 17085120

10

Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?

Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, Catalona WJ. Loeb S, et al. Among authors: yu x. J Urol. 2007 Jan;177(1):102-6; discussion 106. doi: 10.1016/j.juro.2006.08.097. J Urol. 2007. PMID: 17162013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,665 results

Search Page

Filters